- UroToday Home
- Urologic Oncology
The Latest Research on CRPC with Bone Metastases
Recent Abstracts
-
The Effect of Radium-223 Therapy in Agent Orange-Related Prostate Carcinoma.CRPC w/ bone metastasesJanuary 13, 2021
-
Evaluation of safety and dosimetry of 177Lu DOTA-ZOL for therapy of bone metastases.CRPC w/ bone metastasesJanuary 11, 2021
-
External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy.CRPC w/ bone metastasesJanuary 4, 2021
-
Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine.CRPC w/ bone metastasesDecember 29, 2020
-
Bone Infarction Mimicking a Bone Metastasis on 18F-Prostate-Specific Membrane Antigen PET/CT.CRPC w/ bone metastasesDecember 22, 2020
-
Management of cancer pain with analgetic adjuvant and weak opioid in prostate cancer bone metastases: A case series.CRPC w/ bone metastasesDecember 14, 2020
-
Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow.CRPC w/ bone metastasesDecember 11, 2020
-
Mechanobiological evaluation of prostate cancer metastasis to bone using an in vitro prostate cancer testbed.CRPC w/ bone metastasesDecember 10, 2020
-
Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.CRPC w/ bone metastasesDecember 7, 2020
-
The Role of Theranostics in Prostate Cancer.CRPC w/ bone metastasesDecember 2, 2020
Beyond the Abstracts
-
Bone Targeted Therapy and Skeletal Related Events in the Era of Enzalutamide and Abiraterone Acetate for Castration Resistant Prostate Cancer with Bone Metastases - Beyond the AbstractCRPC w/ bone metastasesOctober 27, 2020
-
Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-Preliminary Results of the Response Evaluation Using F-18-Fluoride PET/CT: Beyond the AbstractCRPC w/ bone metastasesApril 7, 2017
-
Prostate Cancer Cure is Possible: Beyond the AbstractCRPC w/ bone metastasesJanuary 5, 2017
-
The use of radium 223 dichloride in a multidisciplinary approach for treating metastatic castration-resistant prostate cancer, "Beyond the Abstract," by Elisa BorsòCRPC w/ bone metastasesFebruary 11, 2015